Results 141 to 150 of about 21,353 (254)

Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis [PDF]

open access: bronze, 2015
Meredith Y. Smith   +6 more
openalex   +1 more source

Safety Assessment of High‐ and Low‐Molecular‐Weight Hyaluronans (Profhilo®) as Derived from Worldwide Postmarketing Data [PDF]

open access: hybrid, 2020
Daniel Cassuto   +5 more
openalex   +1 more source

Real‐world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52‐week analysis of a postmarketing surveillance study in Japan [PDF]

open access: hybrid, 2023
Nobukazu Hayashi   +7 more
openalex   +1 more source

Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study

open access: hybrid, 2020
Alicia Gilsenan   +5 more
openalex   +1 more source

An observational, non-interventional, multicenter, multinational registry of patients with atypical hemolytic uremic syndrome: methodology [PDF]

open access: yes, 2013
Ardissino, Gianluigi   +10 more
core  

Navigating hepatotoxicity of antibody-drug conjugates: from mechanistic insights to clinical and postmarketing evidence. [PDF]

open access: yesFront Pharmacol
Dong Y   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy